What’s so bad about off-label uses of medication?

David Brancaccio and Jeff Horwich Jul 3, 2012
HTML EMBED:
COPY

What’s so bad about off-label uses of medication?

David Brancaccio and Jeff Horwich Jul 3, 2012
HTML EMBED:
COPY

 According to the Justice Department, it’s the biggest settlement in a health-care fraud case in history. GlaxoSmithKline, the huge British drug-maker, will pay $3 billion in fines and compensation to the U.S. government and the states.

That’s for pushing doctors to prescribe drugs for uses that weren’t approved by the FDA, and for failing to inform U.S. regulators of potential dangerous side-effects.

But off-label drug uses are really pretty common. So why is it considered so bad, apparently, that Glaxo has been encouraging off-label uses for prescription drugs?

Here to talk with us in today’s Mid-day Extra is Steven Woloshin, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.

Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.

Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.